These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 31576685)

  • 1. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
    J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of the
    Yang Y; Pan YQ; Wang M; Gu S; Bao W
    Radiat Oncol; 2023 Dec; 18(1):196. PubMed ID: 38049843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
    Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
    Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
    Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS
    Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
    Crivellaro C; Signorelli M; Guerra L; De Ponti E; Pirovano C; Fruscio R; Elisei F; Montanelli L; Buda A; Messa C
    Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
    Calles-Sastre L; Mucientes-Rasilla J; San-Frutos Llorente LM; Royuela A; Garcia-Espantaleón Navas M; Herrero Gámiz S; Pérez-Medina T
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):17-21. PubMed ID: 30366731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.
    Kitajima K; Suenaga Y; Ueno Y; Maeda T; Ebina Y; Yamada H; Okunaga T; Kubo K; Sofue K; Kanda T; Tamaki Y; Sugimura K
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1268-75. PubMed ID: 25833351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
    Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
    BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evaluation of Preoperative
    Vural Topuz Ö; Aksu A; Erinç SR; Tokgözoğlu N; Tamam MÖ
    Mol Imaging Radionucl Ther; 2022 Feb; 31(1):16-22. PubMed ID: 35114747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High metabolic tumor volume and total lesion glycolysis are associated with lateral lymph node metastasis in patients with incidentally detected thyroid carcinoma.
    Kim BH; Kim SJ; Kim K; Kim H; Kim SJ; Kim WJ; Jeon YK; Kim SS; Kim YK; Kim IJ
    Ann Nucl Med; 2015 Oct; 29(8):721-9. PubMed ID: 26108700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
    Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
    Wu LL; Liang JH; Wang L; Xu W; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ
    Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer.
    Mapelli P; Bergamini A; Fallanca F; Rancoita PMV; Cioffi R; Incerti E; Rabaiotti E; Petrone M; Mangili G; Candiani M; Gianolli L; Picchio M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):3-9. PubMed ID: 30573387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
    Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
    Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.